•
Mar 31, 2024

Immunic Q2 2024 Earnings Report

Total Revenue
$0
EPS
-$0.21
Previous year: -$0.54
-61.1%
Gross Profit
-$26K
Cash and Equivalents
$97.3M
Previous year: $77.3M
+25.9%
Free Cash Flow
-$24M
Previous year: -$20M
+20.0%
Total Assets
$104M
Previous year: $88.7M
+17.4%

Immunic

Immunic